Biodexa Pharmaceuticals
BDRX | NASDAQ
$2.80
-$0.63 (-18.37%)
At close: Nov 2, 2026, 4:00 PM ET
$2.98
+$0.18 (+6.43%)
After-hours:
Nov 2, 2026, 5:04 PM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q4 2025 Dec 31, 2025 | Q2 2025 Jun 30, 2025 | Q4 2024 Dec 31, 2024 | Q2 2024 Jun 30, 2024 | Q4 2023 Dec 31, 2023 | Q2 2023 Jun 30, 2023 | Q4 2022 Dec 31, 2022 | Q2 2022 Jun 30, 2022 | Q4 2021 Dec 31, 2021 | Q2 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | 83K | 381K | 529K | 699K | 645K | 578K | 576K |
Cost of Revenue | 129.29K | 1.71M | 4.91M | 5.44M | 4.44M | 4.5M | 4.95M | 5.11M | 5.06M | 4.65M | 5.83M |
Gross Profit | -129.29K | -1.71M | -4.91M | -5.44M | -4.36M | -4.12M | -4.42M | -4.41M | -4.41M | -4.08M | -5.25M |
Operating Income | -9.47M | -8.74M | -8.99M | -9.2M | -7.99M | -8.01M | -8.04M | -7.57M | -7.54M | -7M | -9.61M |
Interest Income | 146.5K | 53.67K | n/a | 88K | 128K | 42K | 8K | 24K | 40K | 44K | 34K |
Pretax Income | -4.34M | -6.47M | -6.52M | -5.98M | -7.06M | -7.49M | -8.95M | -8.49M | -6.11M | -6.11M | -9M |
Net Income | -4.44M | -6.37M | -6.23M | -5.73M | -6.82M | -7.08M | -8.16M | -7.66M | -5.37M | -5.46M | -7.92M |
Selling & General & Admin | 4.15M | 4.84M | 4.14M | 3.79M | 2.78M | 3.03M | 3.62M | 3.18M | 3.14M | 2.95M | 4.4M |
Research & Development | 5.26M | 3.95M | 4.91M | 5.44M | 4.01M | 4.07M | 4.95M | 5.11M | 5.06M | 4.65M | 14.17M |
Other Expenses | -63.85K | -1.76M | -4.97M | -5.47M | -3.14M | -955K | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 9.34M | 7.03M | 4.08M | 3.76M | 3.64M | 3.51M | 4.52M | 4.05M | 1.66M | 1.99M | 3.71M |
Interest Expense | 25.97K | 120.87K | 137K | 86K | 49K | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 8K |
Cost & Expenses | 9.47M | 8.74M | 8.99M | 9.2M | 8.08M | 8.01M | 9.47M | 9.16M | 6.72M | 6.64M | 9.54M |
Income Tax Expense | 104.51K | 224.63K | 40K | -250K | -243K | -406K | -783K | -832K | -747K | -646K | -1.08M |
Shares Outstanding (Basic) | 18.66M | 112.91M | 12.63M | 3.34M | 1.64M | 594.79K | 49.6K | 2.48K | 2.46K | 2.46K | 1.58K |
Shares Outstanding (Diluted) | 18.66M | 112.91M | 12.63M | 3.34M | 1.64M | 594.79K | 49.6K | 2.48K | 2.46K | 2.46K | 1.58K |
EPS (Basic) | -0.04 | -0.44 | -1.32 | -3.48 | -9.96 | -96 | -2.27K | -3.79K | -2.89K | -4.04K | -6.72K |
EPS (Diluted) | -0.04 | -0.44 | -1.32 | -3.48 | -9.96 | -96 | -2.27K | -3.79K | -2.89K | -4.04K | -6.72K |
EBITDA | -9.34M | -8.55M | -8.74M | -8.11M | -5.46M | -6.32M | -7.72M | -7.22M | -7.14M | -6.59M | -8.78M |
EBIT | -9.47M | -8.74M | -8.99M | -8.36M | -5.74M | -6.6M | -8.04M | -7.57M | -7.54M | -7M | -9.61M |
Depreciation & Amortization | 129.29K | 189.31K | 256.82K | 252.21K | 280.22K | 286.85K | 313.56K | 350.69K | 405.68K | 405.79K | 831.2K |
Add to Watchlist
Select watchlists to add or remove BDRX